Axxcess Wealth Management LLC Decreases Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Axxcess Wealth Management LLC decreased its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 12.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,239 shares of the company’s stock after selling 1,394 shares during the period. Axxcess Wealth Management LLC’s holdings in VanEck Pharmaceutical ETF were worth $929,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of PPH. Avestar Capital LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter worth $4,284,000. Raymond James Financial Services Advisors Inc. increased its stake in shares of VanEck Pharmaceutical ETF by 462.4% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 18,148 shares of the company’s stock worth $1,477,000 after acquiring an additional 14,921 shares during the period. Independent Advisor Alliance increased its stake in shares of VanEck Pharmaceutical ETF by 100.8% in the fourth quarter. Independent Advisor Alliance now owns 98,473 shares of the company’s stock worth $7,939,000 after acquiring an additional 49,423 shares during the period. Private Client Services LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter worth $298,000. Finally, Assetmark Inc. increased its stake in shares of VanEck Pharmaceutical ETF by 107.5% in the fourth quarter. Assetmark Inc. now owns 5,485 shares of the company’s stock worth $446,000 after acquiring an additional 2,841 shares during the period.

VanEck Pharmaceutical ETF Price Performance

PPH stock traded up $0.65 during midday trading on Friday, hitting $93.28. 256,744 shares of the stock traded hands, compared to its average volume of 135,693. The firm has a market cap of $619.38 million, a P/E ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 1-year low of $74.05 and a 1-year high of $93.85. The stock’s fifty day simple moving average is $91.57 and its 200-day simple moving average is $89.08.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, July 5th. Shareholders of record on Monday, July 1st were issued a dividend of $0.3558 per share. The ex-dividend date was Monday, July 1st.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.